Evaluation of new iron chelators and their therapeutic potential

被引:48
|
作者
Aouad, F [1 ]
Florence, A [1 ]
Zhang, Y [1 ]
Collins, F [1 ]
Henry, C [1 ]
Ward, RJ [1 ]
Crichton, RR [1 ]
机构
[1] Univ Catholique Louvain, Unite Biochim, B-1348 Louvain, Belgium
关键词
homeostasis; metal ions; chelation;
D O I
10.1016/S0020-1693(02)01040-X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
One of the most important challenges for biological inorganic chemistry is to understand metal ion homeostasis, particularly since we are becoming increasingly aware that its disequilibrium is at the basis of a large number of clinical disorders. It is, therefore, also an important objective of our research to seek solutions, which can alleviate the consequences of the perturbation of the homeostasis of key metal ions within cells, tissues and organisms. Iron is one of the key metals in biology, for which disorders of homeostasis are implicated in a vast panoply of pathological conditions. We review here the ways in which potential iron chelators can be evaluated, using appropriate in vivo or in vitro screening systems, and discuss their potential applications in the chelation of both iron and aluminium in the treatment of a number of human diseases. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:470 / 480
页数:11
相关论文
共 50 条
  • [21] Cardioprotective Potential of Iron Chelators and Prochelators
    Jansova, Hana
    Simunek, Tomas
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (02) : 288 - 301
  • [22] Iron chelators as therapeutic agents for the treatment of cancer
    Richardson, DR
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 42 (03) : 267 - 281
  • [23] NEW EFFECTIVE IRON CHELATORS
    BERGERON, RJ
    STONGE, E
    ELSAWAF, H
    STREIFF, RR
    CLINICAL RESEARCH, 1983, 31 (02): : A309 - A309
  • [24] New developments in iron chelators
    Cunningham, MJ
    Nathan, DG
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (02) : 129 - 134
  • [25] Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
    Raza, Mohsin
    Chakraborty, Sankalpa
    Choudhury, Monjoy
    Ghosh, Prahlad C.
    Nag, Alo
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (12) : 1125 - 1140
  • [26] Preparation and evaluation of 3,2-hydroxypyridinone ligands as therapeutic iron chelators.
    Clarke, KM
    Xu, J
    Watson, G
    Raymond, KN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U814 - U814
  • [27] A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases
    Singh, Yash Pal
    Pandey, Amruta
    Vishwakarma, Swati
    Modi, Gyan
    MOLECULAR DIVERSITY, 2019, 23 (02) : 509 - 526
  • [28] The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa
    Lin, Bin
    Youdim, Moussa B. H.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 174 : 1 - 11
  • [29] A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
    Yash Pal Singh
    Amruta Pandey
    Swati Vishwakarma
    Gyan Modi
    Molecular Diversity, 2019, 23 : 509 - 526
  • [30] New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs
    Arduino, Daniela
    Silva, Daniel
    Cardoso, Sandra M.
    Chaves, Silvia
    Oliveira, Catarina R.
    Santos, M. Amelia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 6763 - 6774